35 Anafylaktiske og andre hypersensitivitetsreaktioner er blevet rapporteret efter intravenøs administration af proteiner, inklusive MabThera, til patienter.
Anaphylactic and other hypersensitivity reactions have been reported following the intravenous administration of proteins, including MabThera, to patients.